Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gubbs, Inc. is a specialized software and consulting firm providing solutions to the biotechnology and pharmaceutical industries, with a focus on laboratory optimization and validation. The company is best known for its Gubbs Mass Spec Utilities (GMSU), a suite of tools designed to enhance data processing throughput in high-throughput ADME and DMPK discovery laboratories. Additionally, Gubbs provides 21 CFR Part 11 compliant metadata management software and comprehensive computer system validation services for chromatography data systems. Founded by Dr. Larry Elvebak, the company helps scientific laboratories streamline workflows and maintain regulatory compliance in FDA-regulated environments. Through its partnership with the Tetra Partner Network, Gubbs integrates its automation expertise with cloud-based data platforms to accelerate drug development insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gubbs.